I remember my exchange during NOCD’s pitch on Shark Tank India, Season 1, Episode 3. I keep Siddharth and Vinay’s statements distinct from my own questions and assessment. I tasted the drink, asked about its flavor, marketing, price, and readiness, and ultimately went out. The discussion also included a name-change suggestion and Vineeta Singh’s offer; the excerpt does not establish whether the founders accepted it or completed a deal.
The NOCD pitch I’m recording here was on Shark Tank India, Season 1, Episode 3.
After tasting the drink, I said, “Bahut hi gandi hai!” and asked whether there was another flavor; I said I might not like berry.
Siddharth reported about 300 stores in Mumbai and 800 stores in Bangalore: “Kuch 300 stores jo hain Mumbai mein hain aur baaki ke 800 stores hamare Bangalore mein hain.” These were his reported counts.
Siddharth quoted the price as 110 rupees a can, and I repeated it: “110 rupees a can.”
I steered the conversation toward marketing, saying I had not heard of NOCD: “Maine toh suna hi nahi NOCD”. I also asked how the name was pronounced.
After confirming with Siddharth that the product and distribution were ready, I said marketing was needed: “Marketing ki zaroorat hai.”
I went out because I did not like the drink, thought the product had been made before good marketing, felt it was too early, and expected the founders would need a lot of work from me: “mujhe lag raha hai bahut kaam karwaoge aap mere se, toh main itna kaam karne ko abhi taiyar nahi hoon, isliye main out hoon.”
I explicitly urged the founders to change the name NOCD: “Aur naam change kar do NOCD ka!”
I praised the product and founders’ potential, saying, “Product mein dam hai, bando mein bhi dam hai, kar lenge.” I joked that the energy came from the deal, not from drinking the drink.
Vineeta Singh offered 20 lakhs of equity for 20% and 30 lakhs of debt. The excerpt records the offer but does not specify final terms or confirm that a deal was completed.
After the deal discussion, I asked what had changed my mind: “How did you change your mind? What made you change your mind?” The transcript does not record my explanation.
Ashneer Grover—not me—said he was out, criticized the name as sounding like a medicine, and argued that shelf placement and marketing mattered.
Vineeta said she liked the product as a BCAA substitute for post-workout recovery. Namita—not me—advised focusing on one or two key molecules rather than a hodgepodge of ingredients.
The transcript leaves open whether NOCD changed its name, ingredients, or marketing after the pitch. It also does not identify the product’s ingredients beyond Vineeta’s BCAA-substitute characterization, or clarify when the reported store counts and price applied.